English HTA OKs AbbVie’s Bispecific Antibody Tepkliny for DLBCL After Initial Refusal

 
• By Francesca Bruce
Money and Injection
English HTA decides On AbbVie's subcutaneous bispecific antibody • Source: Shutterstock

More from Europe

More from Geography